CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 100 enrolled
Drug / intervention
Hydrocodone/Acetaminophen Extended Release +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01333722
NCT01333722Phase 2Completed
CompareCT.gov

A Randomized, Multicenter Study Comparing the Analgesic Efficacy and Safety of Hydrocodone / Acetaminophen Extended Release to Placebo in Subjects With Acute Pain Following Bunionectomy

AbbVie (prior sponsor, Abbott)·interventional·Posted Apr 12, 2011·Updated Apr 8, 2014

In Brief

A Phase 2 clinical trial evaluating Hydrocodone/Acetaminophen Extended Release and Placebo for Pain. Completed, enrolled 100 participants across 3 sites.

Detailed Summary

The primary purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen extended release compared to placebo in the treatment of moderate to severe pain following bunionectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 12, 2011
Enrollment StartApr 1, 2011
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.2 years ago

Interventions

Hydrocodone/Acetaminophen Extended Releasedrug

Placebodrug

Placebo tablet